Increased Precautions We're Taking in Response to COVID-19

LAST UPDATED ON 12/17/2020

As updates on the impact of the coronavirus continue to be released, we want to take a moment to inform you of the heightened preventative measures we have put in place at McCallum Place Eating Disorder Center to keep our patients, their families, and our employees safe. All efforts are guided by and in adherence to the recommendations distributed by the CDC.

Please note that for the safety of our patients, their families, and our staff, on-site visitation is no longer allowed at McCallum Place Eating Disorder Center.

  • This restriction has been implemented in compliance with updated corporate and state regulations to further reduce the risks associated with COVID-19.
  • Options for telehealth visitation are continuously evaluated so that our patients can remain connected to their loved ones.
  • Alternate methods of communication for other services may be offered when deemed clinically appropriate.

For specific information regarding these changes and limitations, please contact us directly.

CDC updates are consistently monitored to ensure that all guidance followed is based on the latest information released.

  • All staff has received infection prevention and control training.
  • Thorough disinfection and hygiene guidance has been provided.
  • Patient care supplies such as masks and hand sanitizer are being monitored and utilized.
  • Temperature and symptom screening protocols are in place for all patients and staff.
  • Social distancing strategies have been implemented to ensure that patients and staff maintain proper distance from one another at all times.
  • Cleaning service contracts have been reviewed for additional support.
  • Personal protective equipment items are routinely checked to ensure proper and secure storage.
  • CDC informational posters are on display to provide important reminders on proper infection prevention procedures.
  • We are in communication with our local health department to receive important community-specific updates.

The safety of our patients, their families, and our employees is our top priority, and we will remain steadfast in our efforts to reduce any risk associated with COVID-19.

The CDC has provided a list of easy tips that can help prevent the spread of the coronavirus.

  • Avoid close contact with people who are sick.
  • Cover your cough or sneeze with a tissue and then immediately dispose of the tissue.
  • Avoid touching your eyes, nose, and mouth.
  • Clean and disinfect objects and surfaces that are frequently touched.
  • Wash your hands often with soap and water for at least 20 seconds.
  • Stay home when you are sick, except to get medical care.

For detailed information on COVID-19, please visit


Binge Eating in Type I Diabetes

Ginger E. Nicol, MD
McCallum Place St. Louis

Binge eating without compensatory purging may be the most common type of disordered eating in Type 1 Diabetes.1 But medical providers, parents and loved ones often don’t think to look for it. Type 1’s who binge eat have chronically higher blood sugars, higher weight, are more likely to experience diabetes complications like retinopathy, and may be at risk for developing “brittle” diabetes – wide swings of blood sugars from high to low associated with mood instability, irritability and fatigue. Most people with Type 1 don’t start off with disordered eating. Although there is little research on the topic, there are probably multiple factors that lead to the onset of binge eating in this population. The good news is that binge eating can be prevented, and also treated – if you know what to look for.

Potential Causes of Binge Eating in Type 1: Psychology & Biology
Psychologically, Type 1 Diabetes requires a constant focus on eating, insulin dosing and blood sugar monitoring. Although the current recommendations are to encourage flexible eating (e.g. allowing some desert or high-carb foods and dosing insulin appropriately), this still feels restrictive to many people because it requires some degree of planning. Additionally, many with Type 1 only allow themselves these sorts of foods when they are treating a low. This is a setup for feeling deprived, while alternatively being rewarded by lows and risking a rebound high from overdoing it.2 Many people notice that after starting on insulin – commonly after several weeks in a state of ketosis and resultant weight loss – there is a notable weight gain, sometimes past that of the normal baseline weight. This may be distressing to many and lead to abnormal shape and weight concerns, especially in girls.

Biologically, the treatment for Type 1, insulin, is an anabolic hormone which helps to store energy as living tissue in our bodies. Excessive exogenous insulin leads to hypoglycemia. Since our brains can only run on sugar, our bodies have developed some pretty dramatic ways to deal with low blood glucose. Counter-regulatory hormones like glucagon and epinephrine are secreted, and the nervous system kicks in with a bang to tell you to EAT. The rule of “15s” – eat 15 grams of carbohydrate and wait 15 minutes—is what most diabetes providers recommend when treating a low. The problem is that blood sugars may lag behind eating by about 15 minutes or so, but your hormones and nervous system don’t know that – together they drive eating until the symptoms resolve. This can contribute to “rebound” hyperglycemia, which may last a few hours while the nervous system and counter-regulatory hormone responses to a low slowly resolve. When hyperglycemic, body tissues are starved for energy because there isn’t enough insulin to move glucose into cells for processing and storage. This can lead to fatigue and hunger, increased food intake and higher insulin doses with resultant hypoglycemia. And then the binge cycle starts all over again.

Risk Factors for Binge Eating in Type 1: Stopping the Cycle Before it Starts
Young girls and women, especially those who have poor body image, depression, anxiety or problems with impulse control prior to being diagnosed, are most likely to engage in disordered eating.3 It’s important for providers to assess for and treat these conditions as insulin therapy is being started. Loved ones and parents can be helpful by learning about flexible eating and insulin dosing, e.g. matching insulin dose to carbohydrate intake. This is known to improve quality of life, problem-solving skills and Hgb A1c in Type 1 Diabetes.4 Providers and parents can be regulated in the face of highs or lows, demonstrating and reinforcing a calm and measured response to both. And practicing radical acceptance is important for everyone in the equation: being healthy is about living with diabetes, and accepting you will sometimes make mistakes. A high or a low is almost always traceable back to a defined event or situation – whether it’s eating-related, insulin dose-related, or stress-related—carefully and non-judgmentally considering these while making adjustments for the future is critical. The only true mistakes in life are the ones we don’t learn from.

Assessment & Treatment of Binge Eating Disorder in Type 1

• Start by looking for clues: High daily insulin doses and wide swings in blood sugar, extreme hypoglycemic reactions and compensatory binges in response to lows, irritability and fatigue, weight gain.

• Ask about relationship to food in a compassionate way: Remember that the nature of the illness itself necessitates an atypical perception of food and nutrition. Specifically ask about urges to binge and whether there are feelings of loss of control while eating. Validate and educate on the biological and psychological reasons for binges.

• Consult with a dietitian: A dietitian, especially one with eating disorder expertise, can be invaluable in working with patients who are binging or are at risk for binging. One of the first steps is to assess whether binges are occurring due to hunger or feeling deprived, and then problem solving to establish an intuitive eating plan that allows for foods that are satisfying but that don’t require a high insulin dose to cover.

• Normalize blood sugar excursions: Encourage insulin dosing prior to eating (up to 30 minutes before, depending on what type of insulin is used), or switch to a quicker-acting insulin like inhaled insulin to avoid post-prandial highs. Assess whether correction doses are appropriate – too high leads to lows and potential binges; too low leads to high blood sugars and potential insulin stacking, or sequential doses to bring down a high that can result in a low later. Aim to gradually decrease total daily insulin dose to minimize the appetitive drive associated with high insulin and high blood sugar.

• Consider medical and psychological treatments: High dose serotonin reuptake inhibitors (SSRI’s) like fluoxetine (Prozac), and stimulants like lisdexamfetamine (Vyvanse) can decrease binge urges and binge episodes. Cognitive Behavioral and Interpersonal therapies (CBT and IPT) have demonstrated effectiveness in decreasing binge episodes. But they can also help people live with and manage their diabetes better by addressing cognitive distortions, developing better coping and emotion regulation strategies, identifying interpersonal roles and transitions that impact health behaviors, and shoring up natural social supports.

1. Scheuing N, Bartus B, Berger G, et al. Clinical characteristics and outcome of 467 patients with a clinically recognized eating disorder identified among 52,215 patients with type 1 diabetes: a multicenter german/austrian study. Diabetes Care. 2014;37(6):1581-1589.
2. Merwin RM, Moskovich AA, Dmitrieva NO, et al. Disinhibited eating and weight-related insulin mismanagement among individuals with type 1 diabetes. Appetite. 2014;81:123-130.
3. Olmsted MP, Colton PA, Daneman D, Rydall AC, Rodin GM. Prediction of the onset of disturbed eating behavior in adolescent girls with type 1 diabetes. Diabetes Care. 2008;31(10):1978-1982.
4. Lowe J, Linjawi S, Mensch M, James K, Attia J. Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course. Diabetes Res Clin Pract. 2008;80(3):439-443.